Zerigo Health

United States
San Diego, California, United States, 92037

Company profile

Zerigo Health company profile

Clarify Medical is innovating a well-established treatment, UVB therapy, to become easier, more convenient, more empowering, and more connected for psoriasis, eczema and vitiligo patients. The company also focused on developing innovative technology, products, and services that improve care for people with chronic skin conditions. Clarify Medical indicated for the localized phototherapeutic treatment of dermatologic conditions such as psoriasis, vitiligo, atopic dermatitis (eczema), seborrheic dermatitis, and leukoderma on all skin types (I-VI). It is the first and only connected phototherapy system that uses an app on the patient’s own smartphone (iOS or Android) to manage the dose, frequency, and duration of UVB light therapy, helping to ensure that patients receive the proper doses recommended by the American Academy of Dermatology and Vitiligo Working Group. The treatment regimen is prescribed by the patient’s physician but monitored and controlled by the Clarify System, enabling patients to administer treatment with clinical precision in the convenience of their homes. The connected system monitors dosing, adherence, compliance, patient progress, and satisfaction.

Business identity

Contact email
[email protected]
Phone number
877 738 6041
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0+
Founded
2014-01-01, Year

Headquarters

Postal code
92037
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
8
Total equity funding
$67.4M
Last funding
Series B / $43M / 2021-10-21
Last equity funding
Series B / $43M
Investors
20
Lead investors
2
Founders
4
Articles
36

Founders and investors

Founders

John E. SchellhornMartyn GrossRemo Moomiaie-Qajar M.D.Remo Qajar

Lead investors

7wire VenturesH.I.G. BioHealth Partners

Investors

7wire VenturesDragoneer Investment GroupGeneral CatalystH.I.G. CapitalSV Health Investors